PRISM Early-Stage Parkinson’s Disease Study

This study is currently closed to enrollment.

AGE: 30 - 80 years old
GENDER: All

TYPE: Investigational Drug Study
CONDITION: Early-stage Parkinson’s Disease

HEALTHY PARTICIPANTS: Yes
COMPENSATION: May be available

Study Purpose

The PRISM Parkinson’s Research Study is evaluating an investigational drug to determine if it might slow down the progression of Parkinson’s disease (PD). Patients who enroll in this study will receive the study drug weekly over a period of 36 weeks. Participants will have about 10 scheduled in-person visits at the study center and 5 scheduled telephone visits. Those who enroll can expect to be in the study for a total of 44 weeks.

Study ID

20192851